QPX-7831

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameQPX-7831
Drug Alias NameBRII-636 prodrugORAvanceQPX-7831BRII-672
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsGram-Negative Bacterial InfectionsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesQpex Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesQpex Biopharma IncBrii Biosciences Inc
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial InfectionsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A